been the translation of discoveries into medical practice. A plan developed in 2001-02 has encouraged transforming efforts in clinical and translational (CT) education and research by providing the resources to support such endeavors. The vision and goals of this plan, Translating Discoveries, are closely aligned with those of the NIH Clinical and Translational Science Award (CTSA) effort. The CTSA program has given the SoM an important opportunity to reassess, refine and refocus these efforts and move to another level in our effort to transform the practice of CTR across the University. The result will be an administrative home, the Stanford Center for Clinical and Translational Education and Research (SCCTER, pronounced ske-ter), which will totally reshape and focus our efforts in enabling and accelerating translational medicine while minimizing overlap and maximizing efficiency. More specifically, we have made substantial strides in creating enhanced education and training opportunities in clinical and translational research (CTR). Three examples of new and innovative educational initiatives include our scholarly concentrations for medical students, our multidisciplinary Biodesign program for engineers, physicians and other biomedical investigators, and our Masters of Science in Medicine (MOM) degree for PhD candidates. The scholarly concentration program is embedded in our new medical student curriculum. Of the seven concentrations, the two most popular (clinical research and community health) are directly relevant to CTR education and training. Our Biodesign program represents a unique CTR training opportunity built around teams of physicians, engineers, and postgraduate students learning how to successfully invent medically useful devices. Our MOM degree affords PhD candidates at Stanford the opportunity to matriculate with our first and second year medical students, integrating their basic science training with the critical foundations of health and human disease and the practice of medicine to provide these students a more fundamental understanding of translational and clinical medicine. In addition to these three recent initiatives, we are attempting to address the future need for well-trained CT researchers by engaging students earlier in their educational pathway. For example, we host several summer science enrichment courses for gifted and disadvantaged high school students. We consider it essential to reach out specifically to low-income and ethnic minority youth, because they are often overlooked by outreach programs. We also are making efforts to encourage more Stanford University undergraduate students to enroll in seminar courses directed by faculty with research interests in CTR and to increase opportunities for these students to work on human health related research projects with our faculty. Early exposure to CT education and training programs will encourage more of these students to consider a CTR-related profession. Numerous didactic courses have been developed by many of our CTR stakeholders, including the Department of Health Research and Policy, several clinical departments, the Office of Postdoctoral Affairs, the General Clinical Research Center (GCRC, now the Clinical and Translational Research Unit, Program Function 4), the Center for Biomedical Ethics, and the Stanford/Packard Center for Translational Research in Medicine (SPCTRM, now the Support Portal, Program Function 3). In addition, our NIH-funded training programs related to CTR (Table 8.1), including 22 T32s, 4 R25s, and 3 K12s, each have developed many seminar courses and journal clubs. Furthermore, all trainees and faculty have access to Masters degree programs in Epidemiology, Health Services Research, and Public Policy, oh our campus, and we have a joint MPH program with the School of Public Health in Berkeley. Other joint degree opportunities are available across the University in the School of Humanities and Science (Biological Sciences and Biophysics), the School of Engineering (Bioengineering, Biomedical Informatics, and Biomechanical Engineering), the Graduate School of Business, and the School of Law. Despite our rich educational environment and concerted efforts to develop a wide range of disciplinespecific and interdisciplinary education and training programs, the preparation of this application has stimulated the development of a plan for accelerated improvement. This plan, described below, has resulted from a faculty-wide survey and deliberations of a CT Education and Training planning committee. The overall goals of our plan are: ? To utilize the considerable faculty and student talent at all seven of Stanford's Schools to improve CT research and education across the enterprise ? To recruit, educate, and train a continuum of outstanding future CT investigators ? To promote awareness of the value and necessity of multidisciplinary and interdisciplinary team research ? To facilitate and coordinate all of our education and training initiatives in the area of CTR.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Mentored Career Development Award (KL2)
Project #
5KL2RR025743-03
Application #
7938120
Study Section
Special Emphasis Panel (ZRR1-SRC (99))
Program Officer
Joskow, Renee
Project Start
2008-05-19
Project End
2013-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
3
Fiscal Year
2010
Total Cost
$463,167
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Holubar, Marisa; Troy, Stephanie B; Nathoo, Kusum et al. (2017) Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants. J Pediatric Infect Dis Soc 6:105-108
Salles, Arghavan; Mueller, Claudia M; Cohen, Geoffrey L (2016) Exploring the Relationship Between Stereotype Perception and Residents' Well-Being. J Am Coll Surg 222:52-8
Kim, S H; Silvers, A; Viren, J et al. (2016) Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic. Diabet Med 33:961-7
Padda, Sukhmani K; Riess, Jonathan W; Schwartz, Erich J et al. (2015) Diffuse high intensity PD-L1 staining in thymic epithelial tumors. J Thorac Oncol 10:500-8
Riess, Jonathan W; West, Robert; Dean, Michelle et al. (2015) GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray. Anticancer Res 35:669-76
Aksel, Tural; Choe Yu, Elizabeth; Sutton, Shirley et al. (2015) Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector. Cell Rep 11:910-920
Riess, Jonathan W; Nagpal, Seema; Iv, Michael et al. (2014) Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era. Clin Lung Cancer 15:202-6
Chock, Valerie Y; Punn, Rajesh; Oza, Anushri et al. (2014) Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus. Pediatr Res 75:570-5
Riess, Jonathan W; Bhattacharya, Nupur; Blenman, Kim R M et al. (2014) Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients. Immunopharmacol Immunotoxicol 36:182-6
Riess, Jonathan W; Padda, Sukhmani K; Bangs, Charles D et al. (2013) A case series of lengthy progression-free survival with pemetrexed-containing therapy in metastatic non--small-cell lung cancer patients harboring ROS1 gene rearrangements. Clin Lung Cancer 14:592-5

Showing the most recent 10 out of 28 publications